Polatuzumab Vedotin With R-GDP in Relapsed/Refractory Diffuse Large B-cell Lymphoma
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
Thomas Jefferson University
M.D. Anderson Cancer Center
Wake Forest University Health Sciences
Roswell Park Cancer Institute
Ohio State University Comprehensive Cancer Center
St. Jude Children's Research Hospital
Hackensack Meridian Health
Dana-Farber Cancer Institute
University College, London
Hackensack Meridian Health
Hackensack Meridian Health
Hackensack Meridian Health
Geneve TEAM Ambulances
University of Nebraska
Washington University School of Medicine
University of Iowa
Stanford University
City of Hope Medical Center
Hackensack Meridian Health
Baylor College of Medicine
Dana-Farber Cancer Institute
University of Massachusetts, Amherst
Thomas Jefferson University
Dana-Farber Cancer Institute
Massachusetts General Hospital
M.D. Anderson Cancer Center
University of Chicago
University of Miami
M.D. Anderson Cancer Center
University of Washington
Mayo Clinic
H. Lee Moffitt Cancer Center and Research Institute
Massachusetts General Hospital
Penn State University
University of Ulm
University of Colorado, Denver
Dana-Farber Cancer Institute
University of Chicago
City of Hope Medical Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Dartmouth-Hitchcock Medical Center
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Mayo Clinic
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute